Korean billionaire's fortune soars as his pharma stocks surge
String of licensing deals with global drugmakers gives Hanmi founder Lim Sung-ki a net worth of about US$2.7b
Seoul
THE South Korean man who founded two drug companies that are among Asia's best performing stocks for the past year is seeing his fortune climb after vaulting into the region's billionaire's club.
Hanmi Science Co has surged 971 per cent while its subsidiary Hanmi Pharmaceutical Co has gained 805 per cent over the last 12 months after a string of licensing deals with global drugmakers. The rally gave founder Lim Sung-ki a net worth of about US$2.7 billion as at Monday's close, according to the Bloomberg Billionaires index.
Hanmi Pharma has in recent months entered into partnerships with international companies including Eli Lilly Co and Sanofi for drugs it is developing as potential treatments for conditions such as diabetes and rheumatoid arthritis. Analys…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
France's Casino supermarket chain to axe up to 3,200 jobs
Prada outshines rivals with 16% revenue lift boosted by Miu Miu
Toymaker Hasbro posts quarterly profit beat, slower sales decline
Hilton lifts 2024 profit forecast on international travel demand
China knockoff raid jolts a global throng of fake-fashion influencers
Roche cuts pipeline after research setbacks and sales drop